NCT06518902View on ClinicalTrials.gov

Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
DRUG

mesenchymal stem cells (umbilical cord) injection

Patients receive mesenchymal stem cells (umbilical cord) injection once or once a week for three consecutive weeks

All Listed Sponsors
lead

National Engineering Center of Cell Products

OTHER

NCT06518902 - Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter